Cyclerion Therapeutics, Inc. (CYCN) › Shares OutstandingCyclerion Therapeutics, Inc. (CYCN) — Shares OutstandingAnnual figures by period end, from SEC filings.2018-12-31: 02019-12-31: 27.60M2020-12-31: 34.05M2021-12-31: 43.41M2022-12-31: 2.18M2023-12-31: 2.47M2024-12-31: 2.55M2025-12-31: 3.82M3.82M2018-12-31Shares Outstanding (shares)2025-12-31Period endedShares OutstandingChange YoYSource filing2025-12-313.82M+50.1%2026-03-30Balance as of period end2024-12-312.55M+2.9%2026-03-30Balance as of period end2023-12-312.47M+13.7%2025-11-12Balance as of period end2022-12-312.18M-95.0%2024-03-05Balance as of period end2021-12-3143.41M+27.5%2023-03-22Balance as of period end2020-12-3134.05M+23.4%2021-02-25Balance as of period end2019-12-3127.60M—2021-02-25Balance as of period end2018-12-310—2020-03-12Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresDividends Per ShareWeighted Average Diluted SharesEPS (Basic)